PP2A has been shown to dephosphorylate and therefore inhibit Src, a non-receptor tyrosine kinase that has been shown to regulate TRAIL resistance in breast cancer cells through mediation of Akt-pathway survival signaling [117,118]. This evidence concerns the gene PTPA and breast cancer.